Christopher Travascio has a general corporate commercial practice.
Prior to joining Bennett Jones as an associate, Christopher summered and articled with the firm. While articling, Christopher was seconded to the Enforcement branch of the Ontario Securities Commission.
- Fluorinov Pharma Inc., a privately-held oncology company, in connection with its $10 million acquisition by Trillium Therapeutics Inc.
- Park Lawn Corporation in connection with the $24.2 million bought deal prospectus offering of 2,105,400 subscription receipts in December, 2015 - Counsel to syndicate of underwriters led by National Bank Financial Inc.
News & Speaking Engagements